Robert Reger

2.7k total citations
55 papers, 1.7k citations indexed

About

Robert Reger is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Robert Reger has authored 55 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 29 papers in Immunology and 19 papers in Hematology. Recurrent topics in Robert Reger's work include Immune Cell Function and Interaction (24 papers), CAR-T cell therapy research (23 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Robert Reger is often cited by papers focused on Immune Cell Function and Interaction (24 papers), CAR-T cell therapy research (23 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Robert Reger collaborates with scholars based in United States, Sweden and Japan. Robert Reger's co-authors include Richard Childs, Pawel Muranski, Zhiya Yu, Nicholas P. Restifo, Steven A. Rosenberg, Mattias Carlsten, Zachary A. Borman, Douglas C. Palmer, Luca Gattinoni and Emily R. Levy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Robert Reger

53 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Reger United States 16 1.2k 1.1k 341 327 168 55 1.7k
Jingjing Li China 20 891 0.8× 369 0.3× 159 0.5× 421 1.3× 63 0.4× 96 1.4k
Yongxian Hu China 17 485 0.4× 203 0.2× 106 0.3× 356 1.1× 250 1.5× 60 996
Hai Cheng China 18 485 0.4× 268 0.2× 159 0.5× 345 1.1× 361 2.1× 88 1.2k
Fabrizio Loiacono Italy 19 285 0.2× 1.1k 1.0× 46 0.1× 178 0.5× 199 1.2× 37 1.5k
Anna Kozłowska Poland 17 499 0.4× 555 0.5× 66 0.2× 287 0.9× 36 0.2× 34 970
Rebar N. Mohammed Iraq 14 393 0.3× 312 0.3× 65 0.2× 196 0.6× 30 0.2× 24 809
Yisi Lu United States 11 346 0.3× 861 0.8× 87 0.3× 198 0.6× 15 0.1× 17 1.3k

Countries citing papers authored by Robert Reger

Since Specialization
Citations

This map shows the geographic impact of Robert Reger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Reger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Reger more than expected).

Fields of papers citing papers by Robert Reger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Reger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Reger. The network helps show where Robert Reger may publish in the future.

Co-authorship network of co-authors of Robert Reger

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Reger. A scholar is included among the top collaborators of Robert Reger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Reger. Robert Reger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Childs, Richard, Xin Tian, Georg Aue, et al.. (2025). REMOVED: Interim Results of a Phase II Trial of Omidubicel, Ex-Vivo Expanded Umbilical Cord Blood Transplantation in Patients with Treatment-Refractory Severe Aplastic Anemia. Transplantation and Cellular Therapy. 31(2). S41–S42. 2 indexed citations
2.
Teague, Heather, Marcos J. Ramos-Benítez, Xin Tian, et al.. (2025). SARS-CoV-2 Immune Complex–Mediated Neutrophil Activation. Open Forum Infectious Diseases. 12(4). ofaf199–ofaf199. 2 indexed citations
3.
Cherkasova, Elena, Timothy T. Spear, Gina Scurti, et al.. (2024). Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus. Journal for ImmunoTherapy of Cancer. 12(9). e009147–e009147. 5 indexed citations
4.
Cherkasova, Elena, Rosa Nadal, Long Chen, et al.. (2023). T cell receptor-engineered T cells targeting a human endogenous retrovirus in kidney cancer.. Journal of Clinical Oncology. 41(16_suppl). 4542–4542. 2 indexed citations
5.
Childs, Richard, Xin Tian, Enkhtsetseg Purev, et al.. (2021). Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome. British Journal of Haematology. 193(5). 951–960. 4 indexed citations
6.
Allan, David, et al.. (2021). Systematic improvements in lentiviral transduction of primary human natural killer cells undergoing ex vivo expansion. Molecular Therapy — Methods & Clinical Development. 20. 559–571. 42 indexed citations
7.
Reger, Robert, Jakob Theorell, Heinrich Schlums, et al.. (2021). LIR‐1 educates expanded human NK cells and defines a unique antitumor NK cell subset with potent antibody‐dependent cellular cytotoxicity. Clinical & Translational Immunology. 10(10). e1346–e1346. 10 indexed citations
8.
Sato, Noriko, Kate Stringaris, Jan Davidson‐Moncada, et al.. (2020). In Vivo Tracking of Adoptively Transferred Natural Killer Cells in Rhesus Macaques Using 89Zirconium-Oxine Cell Labeling and PET Imaging. Clinical Cancer Research. 26(11). 2573–2581. 51 indexed citations
9.
Purev, Enkhtsetseg, Kamille A. West, Tatyana Worthy, et al.. (2020). A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo‐immunized patients. British Journal of Haematology. 189(3). 551–558. 17 indexed citations
10.
Levy, Emily R., Robert Reger, Mélanie Lambert, et al.. (2019). Enhanced Bone Marrow Homing of Natural Killer Cells Following mRNA Transfection With Gain-of-Function Variant CXCR4R334X. Frontiers in Immunology. 10. 1262–1262. 67 indexed citations
11.
Allan, David, Mala Chakraborty, Emily R. Levy, et al.. (2017). High-Efficiency Lentiviral Genetic Modification of Primary Human Natural Killer Cells. Blood. 130. 5566–5566. 2 indexed citations
12.
Carlsten, Mattias, Neha Korde, Ritesh R. Kotecha, et al.. (2016). Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma. Clinical Cancer Research. 22(21). 5211–5222. 134 indexed citations
13.
Pantin, Jeremy, Enkhtsetseg Purev, Xin Tian, et al.. (2016). Effect of high-dose plerixafor on CD34 + cell mobilization in healthy stem cell donors: results of a randomized crossover trial. Haematologica. 102(3). 600–609. 44 indexed citations
14.
15.
Kerkar, Sid P., Romina S. Goldszmid, Pawel Muranski, et al.. (2011). IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. Journal of Clinical Investigation. 121(12). 4746–4757. 262 indexed citations
16.
Ji, Yun, Zoltán Pós, Mahadev Rao, et al.. (2011). Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells. Nature Immunology. 12(12). 1230–1237. 151 indexed citations
17.
18.
Kerkar, Sid P., Pawel Muranski, Andrew Kaiser, et al.. (2010). Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts. Cancer Research. 70(17). 6725–6734. 207 indexed citations
19.
Morgan, W. K. C., et al.. (1997). Health effects of diesel emissions. The Annals of Occupational Hygiene. 41(6). 643–658. 65 indexed citations
20.
Bridbord, Kenneth, Joseph T. Costello, John King Gamble, et al.. (1979). Occupational safety and health implications of increased coal utilization.. Environmental Health Perspectives. 33. 285–302. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingjing Li Breakdown of academic impact, for papers by Yongxian Hu Breakdown of academic impact, for papers by Hai Cheng Breakdown of academic impact, for papers by Fabrizio Loiacono Breakdown of academic impact, for papers by Anna Kozłowska Breakdown of academic impact, for papers by Rebar N. Mohammed Breakdown of academic impact, for papers by Yisi Lu
Rankless by CCL
2026